The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): Analysis in Italian patients

Tumor Biology

Volumn 24, Issue 3, 2003, Pages 147-150

  Ruzzo, Annamaria ^a   Graziano, Francesco ^a,b   Costagliola, Antonello ^a   Arduini, Federica ^c   Testa, Enrica ^b   Bearzi, Italo ^c   Cortese, Giuliana ^d   De Gaetano, Andrea ^d   Andreoni, Francesca ^a   Lai, Vittorio ^b   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b Hospital of Urbino   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

CDH1; E cadherin; Gastric cancer; Germline; Missense mutation

Indexed keywords

ADENINE NUCLEOTIDE; COMPLEMENTARY DNA; GUANINE NUCLEOTIDE; UVOMORULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EPIDEMIC; GENE MUTATION; GENETIC ANALYSIS; HUMAN; ITALY; MOLECULAR DYNAMICS; POPULATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; STOMACH CARCINOMA;

EID: 0345257902     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073844     Document Type: Article

References (33)

1. Takeichi M: Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 1995;7:619-627.
2. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A: The cadherin-catenin adhesion system in signalling and cancer. J Clin Invest 2002;109: 987-991.
3. Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Hofler H, Becker KF: Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999;18: 4301-4312.
4. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I: E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53: 1690-1695.
5. Christofori G, Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999;24: 73-76.
6. Berx G, Becker KF, Hofler H, van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998;12:226-237.
7. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-405.
8. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA, Caldas C: Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998;58:4086-4089.
9. Pharoah PD, Guilford P, Caldas C: International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348-1353.
10. Park JG, Yang HK, Kim WH, Caldas C, Yokota J, Guilford P: Report of the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. J Natl Cancer Inst 2000;92:1781-1782.
11. Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C: Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 2002;19:510-517.
12. Kusano M, Kakiuchi H, Mihara M, Itoh F, Adachi Y, Ohara M, Hosokawa M, Imai K: Absence of microsatellite instability and germ-line mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer. Tumor Biol 2001;22:262-268.
13. Avizienyte E, Launonen V, Salovaara R, Kiviluoto T, Aaltonen L: E-cadherin is not frequently mutated in hereditary gastric cancer. J Med Genet 2001;38:49-52.
14. Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG: Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet 1999;44:177-180.
15. Stone J, Bevan S, Cunningham D, Hill A, Rahman N, Peto J, Marossy A, Houlston RS: Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer 1999;79:1935-1937.
16. Iida S, Akiyama Y, Ichikawa W, Yamashita T, Nomizu T, Nihei Z, Sugihara K, Yuasa Y: Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds. Clin Cancer Res 1999;5:1445-1447.
17. Graziano F, Ruzzo A, Bearzi I, Testa E, Travaglini L, Lai V, Magnani M: Screening E-cadherin germline mutations in Italian patients with familial diffuse gastric cancer. An analysis in the District of Urbino, Region Marche, Central Italy. Tumori 2003;89:255-258.
18. Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P: Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002;19:518-525.
19. Dussaulx-Garin L, Blayau M, Pagenault M, Le Berre-Heresbach N, Raoul JL, Campion JP, David V, Bretagne JF: A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur J Gastroenterol Hepatol 2001;13:711-715.
20. Kim HC, Wheeler JM, Kim JC, Ilyas M, Beck NE, Kim BS, Park KC, Bodmer WF: The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 2000;47:262-267.
21. Handschuh G, Luber B, Hutzler P, Hofler H, Becker KF: Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences. J Mol Biol 2001;314:445-454.
22. Becker KF, Reich U, Schott C, Hofler H: Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995;96:739-740.
23. Nakamura A, Shimazaki T, Kaneko K, Shibata M, Matsumura T, Nagai M, Makino R, Mitamura K: Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat Res 2002;502:19-24.
24. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R: A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000;71:873-877.
25. Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM, Magnani M, Toro T, Burchill T, Futschik ME, Merriman T, Guilford P: Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer. Oncogene 2002;21:8192-8195.
26. Yabuta T, Shinmura K, Tani M, Yamaguchi S, Yoshimura K, Katai H, Nakajima T, Mochiki E, Tsujinaka T, Takami M, Hirose K, Yamaguchi A, Takenoshita S, Yokota J: E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 2002;101:434-441.
27. Jou T, Stewart DB, Stappert J, Nelson WJ, Marrs JA: Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 1995;92: 5067-5071.
28. Huber AH, Weis WI: The structure of the B-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by B-catenin. Cell 2001;105:391-402.
29. Decarli A, La Vecchia C, Cislaghi C, Mezzanotte G, Marubini E: Descriptive epidemiology of gastric cancer in Italy. Cancer 1986;58: 2560-2569.
30. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:1919-1925.
31. Carpenter PM, Al-Kuran RA, Theuer CP: Paranuaclear E-cadherin in gastric adenocarcinoma. Am J Clin Pathol 2002;118:887-894.
32. Terres AM, Pajares JM, O'Toole D, Ahern S, Kelleher D: H. pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol 1998;51:410-412.
33. Hanby AM, Chinery R, Poulsom R, Playford RJ, Pignatelli M: Downregulation of E-cadhe-rin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 1996;148: 723-729.